Mark Chin - 01 Jul 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Director
Signature
/s/ Frank J. Lanza, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Jul 2023
Net transactions value
$0
Form type
4
Filing time
06 Jul 2023, 18:37:54 UTC
Previous filing
23 Jun 2023
Next filing
02 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HARP Common Stock Award $0 +18,656 +102% $0.000000 36,941 01 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). The fully vested RSUs were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500.